SCHEMBL7953706

SCHEMBL7953706

N#Cc1c(Br)c(-c2ccncc2)n2c1CCCC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC1 P33527 9/20 0.43
ABCG2 Q9UNQ0 7/20 0.43
RXFP1 Q9HBX9 1/20 0.43
ALDH1A1 P00352 7/20 0.41
KDM4E B2RXH2 3/20 0.41
HSD17B10 Q99714 3/20 0.41
RECQL P46063 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ABCB1 P08183 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
RAB9A P51151 1/20 0.39
GFER P55789 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
HPGD P15428 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7954850 0.85 ABCC1 (0.43) ABCC1ABCG2RXFP1ALDH1A1KDM4E
SCHEMBL7955460 0.85 ABCC1 (0.43) ABCC1ABCG2RXFP1ALDH1A1KDM4E
SCHEMBL13195261 0.79 PTGS2 (0.43) RXFP1ALDH1A1KDM4EHSD17B10HTT
SCHEMBL7957179 0.75 KMT2A (0.40) ABCC1ALDH1A1KDM4EHTTSMN1; SMN2
SCHEMBL7946444 0.75 ALDH1A1 (0.43) ABCC1ABCG2RXFP1ALDH1A1KDM4E
SCHEMBL7955033 0.75 ALDH1A1 (0.43) ABCC1ABCG2RXFP1ALDH1A1KDM4E
SCHEMBL7587234 0.74 ABCC1 (0.44) ABCC1ABCG2RXFP1ALDH1A1KDM4E
SCHEMBL7590017 0.71 CYP11B2 (0.44) ABCC1ABCG2RXFP1ALDH1A1KDM4E
SCHEMBL2158205 0.71 KDM4E (0.45) ABCC1ABCG2ALDH1A1KDM4EHSD17B10
SCHEMBL7953813 0.71 ABCC1 (0.43) ABCC1ABCG2RXFP1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194426-B1 CONTROLLING TUMOR NECROSIS FACTOR RHONA-POULENC RORER S.A. (FR) 2001-02-27 US disclosed
EP-0833635-A1 NOVEL USE FOR PYRROLE DERIVATIVES Aventis Pharma S.A. (FR) 1998-04-08 EP disclosed
WO-1997000073-A1 NOVEL USE FOR PYRROLE DERIVATIVES RHONE-POULENC RORER S.A. (FR) 1997-01-03 WO disclosed